<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
<title>Faculty of General Medicine</title>
<link href="https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/429" rel="alternate"/>
<subtitle/>
<id>https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/429</id>
<updated>2026-06-03T20:22:33Z</updated>
<dc:date>2026-06-03T20:22:33Z</dc:date>
<entry>
<title>A study of microalbuminuria in patients with rheumatoid arthritis</title>
<link href="https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/6200" rel="alternate"/>
<author>
<name>Bheeman Gouda, Rajesh M Honnutagi, Prakash M Patil</name>
</author>
<id>https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/6200</id>
<updated>2026-05-16T07:06:49Z</updated>
<published>2026-03-01T00:00:00Z</published>
<summary type="text">A study of microalbuminuria in patients with rheumatoid arthritis
Bheeman Gouda, Rajesh M Honnutagi, Prakash M Patil
Background: Rheumatoid arthritis (RA) is a chronic inflammatory disorder with &#13;
potential systemic complications including renal involvement. Microalbuminuria &#13;
represents early endothelial dysfunction and may indicate disease severity and &#13;
cardiovascular risk in RA patients. The aim of the study is to determine the prevalence of &#13;
microalbuminuria in patients with rheumatoid arthritis and to examine its correlation &#13;
with disease activity markers including rheumatoid factor (RF), erythrocyte &#13;
sedimentation rate (ESR), and C-reactive protein (CRP). Methods: The study included 40 &#13;
patients with established rheumatoid arthritis diagnosed according to the 2020 American &#13;
College of Rheumatology-European Alliance of Associations for Rheumatology (ACR&#13;
EULAR) classification criteria. Patients underwent comprehensive clinical assessment &#13;
including detailed history, physical examination with tender and swollen joint counts, and &#13;
laboratory investigations. Microalbuminuria was assessed using spot morning urine &#13;
samples with albumin-to-creatinine ratio (ACR) method, defining microalbuminuria as &#13;
ACR more than or equal to 30 mg/g. Disease activity markers including ESR, CRP, and RF &#13;
were measured using standard laboratory methods. Statistical analysis was performed &#13;
using appropriate parametric and non-parametric tests, with p value less than 0.05 &#13;
considered statistically significant.  Results: Microalbuminuria was present in 8 out of 40 &#13;
patients (20%). Patients with microalbuminuria demonstrated significantly elevated &#13;
inflammatory markers compared to those without microalbuminuria. Mean ESR was &#13;
48.8±13.7 mm/hr in the microalbuminuria-positive group versus 31.6±12.2 mm/hr in the &#13;
microalbuminuria- negative group (p=0.001). Mean CRP levels were 29.2±8.4 mg/L in &#13;
microalbuminuria-positive patients compared to 20.06±12.1 mg/L in microalbuminuria&#13;
negative patients (p=0.05). Rheumatoid factor showed a strong association with &#13;
microalbuminuria, with 100% (8/8) of microalbuminuria-positive patients being RF &#13;
positive compared to 62.5% (20/32) of microalbuminuria-negative patients (p=0.038).  &#13;
Conclusion: Microalbuminuria was present in 20% of rheumatoid arthritis patients and &#13;
showed significant correlations with disease activity markers including ESR, CRP, and RF. &#13;
These findings establish microalbuminuria as a valuable biomarker of disease severity &#13;
and systemic inflammation in RA. Routine microalbuminuria screening should be &#13;
considered in RA patients, especially those with high disease activity or elevated &#13;
inflammatory markers.
</summary>
<dc:date>2026-03-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>SERUM URIC ACID AS AN INDEPENDENT RISK FACTOR IN  ACUTE ISCHEMIC STROKE: A CROSS-SECTIONAL STUDY</title>
<link href="https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/6188" rel="alternate"/>
<author>
<name>Dr. Nethra N1*, Dr. Rajesh M Honnutagi2, Dr. Gurusangappa S Mudagall3</name>
</author>
<id>https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/6188</id>
<updated>2026-05-14T11:16:28Z</updated>
<published>2026-01-01T00:00:00Z</published>
<summary type="text">SERUM URIC ACID AS AN INDEPENDENT RISK FACTOR IN  ACUTE ISCHEMIC STROKE: A CROSS-SECTIONAL STUDY
Dr. Nethra N1*, Dr. Rajesh M Honnutagi2, Dr. Gurusangappa S Mudagall3
</summary>
<dc:date>2026-01-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>A Study on Social, Demographical and Etiological Risk Factors of Ischemic Stroke in Young.</title>
<link href="https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/5629" rel="alternate"/>
<author>
<name>S Vinod Kumar Reddy, Rajesh M Honnutagi, Ashwini Hiremath, Chaitanya Patil.</name>
</author>
<id>https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/5629</id>
<updated>2024-11-13T11:16:02Z</updated>
<published>2024-01-01T00:00:00Z</published>
<summary type="text">A Study on Social, Demographical and Etiological Risk Factors of Ischemic Stroke in Young.
S Vinod Kumar Reddy, Rajesh M Honnutagi, Ashwini Hiremath, Chaitanya Patil.
</summary>
<dc:date>2024-01-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>Managing Amitraz Poisoning: Epidemiological Data and Clinical Insights From a Tertiary Care Hospital in Southern India</title>
<link href="https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/5623" rel="alternate"/>
<author>
<name>Vishwanath Malkappa Jalawadi, Shravankumar Potkar, Upendra Prasad Yadav, Manjunath S. Hiremani.</name>
</author>
<id>https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/5623</id>
<updated>2024-11-13T10:58:11Z</updated>
<published>2024-01-01T00:00:00Z</published>
<summary type="text">Managing Amitraz Poisoning: Epidemiological Data and Clinical Insights From a Tertiary Care Hospital in Southern India
Vishwanath Malkappa Jalawadi, Shravankumar Potkar, Upendra Prasad Yadav, Manjunath S. Hiremani.
</summary>
<dc:date>2024-01-01T00:00:00Z</dc:date>
</entry>
</feed>
